Tight range until results day IMO (18 Feb).
Shouldn't be any surprises for 2020 actuals as it's just the sum of the quarterlies.
Watching for commentary re 2021 forecast different to analyst forecasts. I've seen USD4,080m EBITDA on USD5,098m revenue.
Cost side seems tight, especially after layoffs due to COVID in 2020. Capex seems reasonable for a business of WPLs size, especially with Sangomar selldown. Production slipping from 100mboe in 2020 and forecast to be 90-95 for 2021 due to Trains 2 and 4 shutdowns is a problem. Think there's some downside risk with this, hoping WPL are being conservative here.
Interested to see dividend movement too, GS have 5.8% yield for 2021 and 6.3% for 2022 (net!!). If markets are efficient, and especially in this era of low risk free rate, WPL should be gobbled up purely for the yield and moving well into the 30s.
So more than anything looking for stability with no surprises. The market will do the rest.
- Forums
- ASX - By Stock
- WDS
- $60 oil price overnight
$60 oil price overnight, page-2
Featured News
Add WDS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$24.00 |
Change
0.350(1.48%) |
Mkt cap ! $45.56B |
Open | High | Low | Value | Volume |
$23.74 | $24.03 | $23.71 | $125.4M | 5.243M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 477 | $23.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$24.02 | 1177 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 23.960 |
1 | 670 | 23.930 |
2 | 58 | 23.910 |
4 | 2670 | 23.900 |
2 | 12000 | 23.880 |
Price($) | Vol. | No. |
---|---|---|
24.050 | 1620 | 3 |
24.060 | 300 | 1 |
24.080 | 800 | 1 |
24.100 | 7031 | 4 |
24.110 | 5000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
WDS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online